Skip to main content

Brazil's Biopharmaceutical Sector Contributes To Economic Growth, Expands Access To Healthcare


Washington, DC-MD-VA-WV - Global Health Progress (GHP) released a new report that reveals how the biopharmaceutical sector in Brazil, the tenth largest biopharmaceutical market in the world and the largest in Latin America, is an important driver for its economy. For instance, Brazil's biopharmaceutical sector develops high-quality, highly skilled jobs, which is a key factor in creating a stable economy. Currently, approximately 821 biotechnology companies in Brazil employ almost 100,000 people with an average annual salary of approximately US $4,457. Among those companies, six biopharmaceutical companies were featured in a 2003 list of the top 100 companies to work for in Brazil.

Not only does the biopharmaceutical sector produce valuable job opportunities for highly skilled workers, this emerging market plays a critical role in fostering public-private partnerships, which leads to more economic growth and greater access to healthcare for its citizens. 

Investment in research and development (R&D) and promoting innovation are key ways the Brazilian government is helping drive future growth of the country's biopharmaceutical sector. For instance, R&D investments in Brazil have increased to 1.5% of GDP in 2010 and there are more than 205 highly trained physicians per 100,000 of the population serving as investigators for clinical studies. 

"In Brazil, promoting innovation is a public policy priority," stated Rafael Oliva, Advisor to the Presidency at the Brazilian Development Bank. "The participation of the Brazilian government in research and development (R&D) is considerable, and the goal is to both increase innovative activities in Brazil on a systematic basis, and to consolidate the country's culture of innovation."

GHP fact sheet shows how Brazil's investment in research and development (R&D) will create positive effects throughout the economy, including improving access to healthcare for its citizens through the production of new medicines. The growing field of clinical trials is also a significant factor in improving access to healthcare. Brazil's large population of 190 million people, with 8 out of every 10 residents living in or near a city, means clinical trial recruitment and participation is fairly robust.

Brazil's robust investment in promoting innovation is contributing to the global expansion of the biopharmaceutical sector, which in turn creates a positive effect on the overarching global health goals of fostering global competitiveness, reducing the health and economic burden of disease on local citizens, developing tomorrow's medicines and expanding access to healthcare. Please view full PDF for additional information and list of sources.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

Comments

Popular posts from this blog

Yellow Fever Vaccination is given only between 10 am and 4 pm everyday. Appointment necessary!

Vaccination Appointment for International Travelers (VAIT) Yellow Fever Vaccination is given only between 10 am and 4 pm everyday. Mail a copy of your passport to info@hopehospital.com before your appointment date. Yellow fever : ·        Mandatory vaccination against yellow fever is carried out to prevent the importation of yellow fever virus into vulnerable countries. These are countries where yellow fever does not occur but where the mosquito vector and non-human primate hosts are present. Importation of the virus by an infected traveller could potentially lead to the establishment of infection in mosquitoes and primates, with a consequent risk of infection for the local population. In such cases, vaccination is an entry requirement for all travellers arriving from countries, including airport transit, where there is a risk of yellow fever transmission. If yellow fever vaccination is contraindicated for medical reasons, a medical certificate is required for

PROTECT your joints now, or pay later.

See the full gallery on Posterous That’s the message of today’s article, which could be headlined Joint Economics. If you are one of the more than 400,000 people a year who have already had one or more hips or knees replaced — or someone who already has no choice but to consider joining their ranks — we offer our sympathies or encouragement or even congratulations, depending on how you are faring. But this column is for people who are not yet destined to necessarily become part of those statistics. Although the human body has an amazing capacity to repair itself, our joints are surprisingly fragile. When the cartilage that cushions bones wears away, it does not grow back. Thinning cartilage contributes to   osteoarthritis , also known as degenerative   arthritis , a painful and often debilitating condition. Over time, arthritic joints can become so sore and inflamed that they need to be replaced with mechanical substitutes. A result: more pain, at least in the short

Today is World Kindness Day!

Today is World Kindness Day! - why not use spare time to send a handwritten letter to someone? someone who is sick or in hospital. someone who is old and lonely. Can be an admirer, friend, neighbor, or perhaps a stranger (like somebody serving in the military). #WorldKindnessDay